Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

103.77
+0.59000.57%
Volume:31.36K
Turnover:3.25M
Market Cap:4.37B
PE:-100.91
High:103.96
Open:103.02
Low:102.54
Close:103.18
52wk High:107.69
52wk Low:85.36
Shares:42.15M
Float Shares:42.15M
Volume Ratio:0.20
T/O Rate:0.07%
Dividend:1.45
Dividend Rate:1.39%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.13
PE(LYR):-100.91

Loading ...

Abbvie - Rinvoq Approved in EU for Pjia in Patients Aged Two Years and Older

THOMSON REUTERS
·
Yesterday

Nexsen Seeks ASX Trading Halt Ahead of RAPID-GBS Trial Update

TIPRANKS
·
Yesterday

Eli Lilly and Company Breaks Ground on $6.5 Billion Houston Manufacturing Site

MT Newswires Live
·
Yesterday

Eli Lilly: Breaks Ground on Fifth U.S. API Manufacturing Site in Houston

THOMSON REUTERS
·
Yesterday

Eli Lilly: Houston Facility to Manufacture Active Pharmaceutical Ingredients for Medicines Like Foundayo

THOMSON REUTERS
·
Yesterday

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Nvidia Corp., Merck Share Gains Lead Dow's 425-Point Climb

Dow Jones
·
Yesterday

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients taking Foundayo

TIPRANKS
·
Yesterday

Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO

MT Newswires Live
·
Sep 21

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

J&J says Caplyta Phase 3 study in bipolar I met primary endpoint

TIPRANKS
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

AbbVie, Iambic Sign Multiyear Drug Discovery Deal

MT Newswires Live
·
Sep 21

AbbVie Partners with Iambic to Accelerate AI-Driven Small-Molecule Drug Discovery

Reuters
·
Sep 21

Johnson & Johnson Says Phase 3 Trial Shows Caplyta Cuts Bipolar I Mania Symptoms by Week 3

Reuters
·
Sep 21

Abbvie and Iambic Announce Collaboration to Accelerate AI-Driven Drug Discovery

THOMSON REUTERS
·
Sep 21

Abbvie - Iambic to Receive Upfront Payment, Milestone Payments, and Tiered Royalties from Collaboration

THOMSON REUTERS
·
Sep 21

Abbvie - Partnership to Accelerate Small Molecule Drug Discovery in Immunology, Neuroscience, Oncology

THOMSON REUTERS
·
Sep 21